Sidestepping the contentious use of stem cells derived from embryos, researchers at the University of Rochester have unveiled a new device technology that makes it feasible to harvest stem cells from the blood.
Potentially improving the prognosis for many cancer sufferers, the technology is also being developed into an anti-cancer implant that programs cancer cells to die. The technique may even produce implants that direct the body
